Tezspire is a medicine used to treat adults and adolescents (12 years of age and older) with severe asthma. It is used as an additional treatment in adults and adolescents with severe asthma that is not adequately controlled by a combination of high-dose corticosteroids taken by inhalation plus another asthma medicine. Tezspire contains the active substance tezepelumab.
Therapeutic Indication
### Therapeutic indication Tezspire is indicated as an add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.
Therapeutic Area (MeSH)
ATC Code
R03DX11
ATC Item
tezepelumab
Pharmacotherapeutic Group
Drugs for obstructive airway diseases
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| tezepelumab | N/A | Tezepelumab |
EMA Name
Tezspire
Medicine Name
Tezspire
Aliases
N/ANo risk management plan link.
